SIRT3 and gallbladder cancer: For example, reduced expression of sirtuin 3 (SIRT3) in patients with gallbladder cancer leads to the inhibition of ACSL4 through AKT serine/threonine kinase (AKT/PKB) signaling, in contrast to the normal tissues surrounding the cancer.